Whole-Brain Radiotherapy (WBRT)

RADIATION2 trials

Sponsors

Maria Sklodowska-Curie National Research Institute of Oncology, Lawrence D Recht

Conditions

Brain MetastasesGlioblastomaGlioblastoma With Primitive Neuronal ComponentGliosarcomaMalignant GliomaOligodendroglial Component Present

Phase 2

Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma

CompletedNCT03746080

Lawrence D RechtGlioblastoma, Glioblastoma With Primitive Neuronal Component, Gliosarcoma +2

Start: 2018-12-04End: 2024-02-08Updated: 2025-11-14

Phase 3

Stereotactic Radiotherapy of Resection Cavity For Single Brain Metastasis Versus Whole-Brain Radiotherapy After Resection

Maria Sklodowska-Curie National Research Institute of OncologyBrain Metastases

Start: 2012-01-31End: 2014-12-31Target: 100Updated: 2012-02-17

Related Papers

A phase II study of plerixafor combined with whole brain radiation therapy (WBRT) for patients with newly diagnosed glioblastoma.

Journal of Clinical Oncology2024-06-012 citations

Quality of life after whole brain radiotherapy compared with radiosurgery of the tumor bed: results from a randomized trial.

2017-06-1421 citations